Welcome to Santa Cruz Biotechnology!

VEGF Antibodies

Santa Cruz Biotechnology, Inc. offers a broad range of VEGF antibodies. Select VEGF antibodies from several monoclonal and/or polyclonal VEGF antibodies listed below. View detailed VEGF antibody specifications by linking to the specific product blocks. Select appropriate VEGF antibodies for your research by isotype, epitope, applications and species reactivity. VEGF gene silencer products in siRNA, shRNA Plasmid and shRNA Lentiviral Particle formats are also available.

Introducing HOVERcruz™,

a unique system for rapid identification of VEGF Antibodies. Hover over product names in the table to see representative data for each product.

Live chat is now available! (click here)

Our live chat system is available to answer your product and ordering questions.

See VEGF Inhibitors for functional analysis of cellular responses to VEGF.

Also see additional VEGF Antibodies including, EG-VEGF, VEGF-B, VEGF-C, VEGF-D

PRODUCT NAMECAT. #ISOTYPEEPITOPEAPPLICATIONSSPECIESCITATIONSRATING
EG-VEGF (E-12)sc-390741mouse IgG2b (h)WB, IP, IF, ELISAhumanNEW
EG-VEGF (H-40)sc-48835rabbit IgG66-105 (h)WB, IP, IFm, r, h, e, c, b1
EG-VEGF (P-15)sc-30345goat IgGInternal (h)WB, IF, ELISAm, r, h, e, c, b, a
EG-VEGF (T-16)sc-21022goat IgGN-terminal (h)WB, IF, ELISAh, e, c, b, p
EG-VEGF (A-12)sc-30343goat IgGN-terminal (h)WB, IF, ELISAm, r, h, e, c, p2
VEGF (147)sc-507rabbit IgG1-140 (h)WB, IP, IF, ELISAm, r, h, Xenopus, e, c, b, p129
VEGF (F-5)sc-365578mouse IgMN-terminal (h)WB, IP, IF, ELISAm, hNEW
VEGF (C-1)sc-7269mouse IgG2a1-140 (h)WB, IP, IF, IHC(P)m, r, h136
VEGF (P-20)sc-1836goat IgGN-terminal (m)WB, IP, IF, ELISAm, r34
VEGF (A-20)sc-152rabbit IgGN-terminal (h)WB, IP, IF, IHC(P), ELISAh, b > m, r289
VEGF (VG-1)sc-53462mouse IgG1FL (m)WB, IP, IF, IHC(P)m, r, h, c8
VEGF (VG76e)sc-53463mouse IgG1FL (h)WB, IPhuman
VEGF (SPM225)sc-65617mouse IgG1FL (h)WB, IP, IF, IHC(P)m, r, h, canine1
VEGF (JH121)sc-57496mouse IgG1FL (h)WB, IP, IF, IHC(P), ELISAm, r, h15
VEGF-B (C-19)sc-1876goat IgGC-terminal (h)WB, IF, IHC(P), ELISAm, r, h, e, c, b, p5
VEGF-B (H-70)sc-13083rabbit IgG1-70 (h)WB, IP, IF, ELISAm, r, h, b, p14
VEGF-B (56-1)sc-81670mouse IgG1C-terminal (h)WB, IFhuman
VEGF-B (P-19)sc-1877goat IgGN-terminal (m)WB, IF, ELISAm, r2
VEGF-B (N-19)sc-1878goat IgGN-terminal (h)WB, IF, ELISAh, b, p8
VEGF-B (RM0008-6E72)sc-101582rat IgG2FL (m)WB, IP, IF, IHC(P)mouse
VEGF-B (MM0008-7B43)sc-101581mouse IgG1FL (h)WB, IP, IFhuman
VEGF-B (J-14I)sc-80442mouse IgG1FL (h)WB, IP, IF, IHC(P), ELISAm, h3
VEGF-C (E-6)sc-374628mouse IgG2a103-137 (h)WB, IP, IF, ELISAm, r, hNEW
VEGF-C (C-20)sc-1881goat IgGC-terminal (h)WB, IP, IF, ELISAm, r, h, c, p26
VEGF-C (A-5)sc-74584mouse IgM230-419 (h)WB, IP, IF, ELISAm, h
VEGF-C (A-18)sc-7132goat IgGN-terminal (m)WB, IP, IF, ELISAm, r6
VEGF-C (A-16)sc-27128goat IgGN-terminal (h)WB, IP, IF, ELISAm, r, h, c, b, p, a, e
VEGF-C (F-10)sc-74585mouse IgG2a230-419 (h)WB, IP, IF, ELISAhuman3
VEGF-C (F-5)sc-398004mouse IgM29-52 (h)WB, IP, IF, ELISAm, r, hNEW
VEGF-C (N-19)sc-7133goat IgGN-terminal (h)WB, IF, ELISAm, r, h15
VEGF-C (H-48)sc-25783rabbit IgG178-225 (h)WB, IP, IF, ELISAm, r, h, c, b, p, a, e3
VEGF-C (H-190)sc-9047rabbit IgG230-419 (h)WB, IP, IF, ELISAm, r, h, c, p, e26
VEGF-C (30AT1174.77.260)sc-130289mouse IgG1N/AWB, IP, ELISAm, h
VEGF-C (MM0006-2E65)sc-101583mouse IgG2FL (h)WB, IPhuman
VEGF-D (C-12)sc-373866mouse IgG1330-353 (h)WB, IP, IF, ELISAhumanNEW
VEGF-D (C-18)sc-7602goat IgGC-terminal (h)WB, IP, IF, ELISAhuman8
VEGF-D (E-17)sc-27131goat IgGInternal (h)WB, IF, ELISAm, r, hNEW
VEGF-D (F-20)sc-27130goat IgGN-terminal (h)WB, IF, ELISAm, r, hNEW
VEGF-D (G-19)sc-6314goat IgGN-terminal (m)WB, IF, IHC(P), ELISAm, r
VEGF-D (H-144)sc-13085rabbit IgG211-354 (h)WB, IP, IF, ELISAm, r, h, e13
VEGF-D (H-45)sc-25784rabbit IgG158-202 (h)WB, IP, IF, ELISAm, r, h, e, c, b, p
VEGF-D (M-16)sc-6313goat IgGC-terminal (m)WB, IF, IHC(P), ELISAm, r
VEGF-D (N-19)sc-7603goat IgGN-terminal (h)WB, IP, IF, ELISAhuman4

VEGF siRNA, shRNA Plasmid and shRNA Lentiviral Particles gene silencers include:

siRNAsshRNA PlasmidsshRNA Lentiviral ParticlesCITATIONSRANKING
VEGF siRNA (h): sc-29520VEGF shRNA Plasmid (h):
sc-29520-SH
VEGF shRNA (h)
Lentiviral Particles: sc-29520-V
5
VEGF siRNA (h2): sc-44278VEGF shRNA Plasmid (h2):
sc-44278-SH
VEGF shRNA (h2)
Lentiviral Particles: sc-44278-V
VEGF siRNA (m): sc-36815VEGF shRNA Plasmid (m):
sc-36815-SH
VEGF shRNA (m)
Lentiviral Particles: sc-36815-V
VEGF-B siRNA (h): sc-39840VEGF-B shRNA Plasmid (h):
sc-39840-SH
VEGF-B shRNA (h)
Lentiviral Particles: sc-39840-V
VEGF-B siRNA (m): sc-39841VEGF-B shRNA Plasmid (m):
sc-39841-SH
VEGF-B shRNA (m)
Lentiviral Particles: sc-39841-V
VEGF-C siRNA (h): sc-39842VEGF-C shRNA Plasmid (h):
sc-39842-SH
VEGF-C shRNA (h)
Lentiviral Particles: sc-39842-V
VEGF-C siRNA (m): sc-39843VEGF-C shRNA Plasmid (m):
sc-39843-SH
VEGF-C shRNA (m)
Lentiviral Particles: sc-39843-V
VEGF-D siRNA (h): sc-39844VEGF-D shRNA Plasmid (h):
sc-39844-SH
VEGF-D shRNA (h)
Lentiviral Particles: sc-39844-V
1
VEGF-D siRNA (m): sc-39845VEGF-D shRNA Plasmid (m):
sc-39845-SH
VEGF-D shRNA (m)
Lentiviral Particles: sc-39845-V
Not Rated
EG-VEGF siRNA (h): sc-45392EG-VEGF shRNA Plasmid (h):
sc-45392-SH
EG-VEGF shRNA (h)
Lentiviral Particles: sc-45392-V
Not Rated
EG-VEGF siRNA (m): sc-45393EG-VEGF shRNA Plasmid (m):
sc-45393-SH
EG-VEGF shRNA (m)
Lentiviral Particles: sc-45393-V
Not Rated

The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast growth factor (FGF), platelet derived growth factor (PDGF) and vascular endothelial growth factor (VEGF). Several forms of VEGF have been identified, including VEGF, VEGF-B, VEGF-C and VEGF-D (also designated FIGF). Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) induces proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands. EG-VEGF is an example of a class of highly specific mitogens that act to regulate proliferation and differentiation of the vascular endothelium in a tissue-specific manner.